1Fracanzani AL,Valenti L,Bugianesi E. Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels:a role for insulin resistance and diabetes[J].Hepatology,2008.792-798.
2Perseghin G,Lattuada G,De Cobelli F. Increased mediastinal fat and impaired left ventricular energy metabolism in young men with newly found fatty liver[J].Hepatology,2008.51-58.
3Minehira K,Young SG,Villanueva CJ. Blocking VLDL secretion causes hepatic steatosis but does not affect peripheral lipid stores or insulin sensitivity in mice[J].Journal of Lipid Research,2008.2038-2044.
4Caballero F,Fernández A,De Lacy AM. Enhanced free cholesterol,SREBP-2 and StAR expression in human NASH[J].Journal of Hepatology,2009.789-796.
7Puri P,Baillie RA,Wiest MM. A lipidomic analysis of nonalcoholic fatty liver disease[J].Hepatology,2007.1081-1090.
8Marí M,Caballero F,Colell A. Mitochondrial free cholesterol loading sensitizes to TNF-and Fas-mediated steatohepatitis[J].CELL METABOLISM,2006.185-198.
9Hamaguchi M,Kojima T,Takeda N. The metabolic syndrome as a predictor of nonalcoholic fatty liver disease[J].Annals of Internal Medicine,2005.722-728.
10Wang D,Wei Y,Pagliassotti MJ. Saturated fatty acids promote endoplasmic reticulum stress and liver injury in rats with hepatic steatosis[J].Endocrinology,2006.943-951.
3Fatty Liver and Alcoholic Liver Disease Study Group of the Chinese Liver Disease Association..非酒精性脂肪性肝病诊疗指南[J].中华肝脏病杂志,2006,14(3):161-163. 被引量：1513
4Kannel WB,Dawber TR,Kagan A,et al.Factors of risk in the development of coronary heart disease-six year follow-up experience.The Framingham Study[J].Ann Intern Med,1961,55:33-50.
5Horton JD,Shah NA,Warrington JA,et al.Combined analysis of oligonucleotide microarray data from transgenic and knockout mice identifies direct SREBP target genes[J].Proc Natl Acad Sci,2003,100(21):12027-12032.
6Yokoyama C,Wang X,Briggs MR,et al.SREBP-1,a basic-helix-loop-helix-leucine zipper protein that controls transcription of the low density lipoprotein receptor gene[J].Cell,1993,75(1):187-197.
7Miserez AR,Muller PY,Barellal L,et al.Sterol regulatory element-binding protein (SREBP)-2 contributes to polygenic hypercholesterolaemia[J].Atherosclerosis,2002,164(1):15-26.
8Robinet P,Vedie B,Chironi J,et al.Characterization of polymorphic structure of SREBP-2 gene:role in atherosclerosis[J].Atherosclerosis,2003,168(2):381-387.
9Horton JD,Shimomura I,Brown MS,et al.Activation of cholesterol synthesis in preference to fatty acid synthesis in liver and adipose tissue of transgenic mice overp roducing sterol regulatory element-binding protein2[J].Clin Invest,1998,101(1):2331-2339.
10Brown MS,Goldstein JL.The SREBP pathway:Regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor[J].Cell,1997,89(3):331-340.
1Inagaki T, Choi M, Moschetta A, et al. Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis[J]. Cell Metab, 2005,2(4):217-225. DOI: 10.1016/ j.cmet.2005.09.001.
2Modica S, Petruzzelli M, Bellafantc E, et al. Selective activation of nuclear bile acid receptor FXR in the intestine protects mice against eholestasis[J]. Gastroenterology, 2012, 142(2):355- 365. el-4. DOI: 10.1053/j.gastro.2011.10.028.
3Kim YC, Fang S, Byun S, et al. Farnesoid X receptor-induced lysine-specifie histone demethylase reduces hepatic bile acid levels and protects the liver against bile acid toxicity[J]. Hepatology, 2015,62(1):220-231. DOI: lO.1002/hep.27677.
4Langhi C, Le MC, Kourimate S, et al. Activation of the farnesoid X receptor represses PCSK9 expression in human hepatoeytes[J]. FEBS Lett, 2008, 582(6):949-955. DOI: 10.1016/j.febslet.2008.02.038.
5Zhang Y, Lee FY, Barrera G, et al. Activation of the nuelear receptor FXR improves hyperglycemia and hyperlipidemia in diabetic mice[J]. Proe Natl Aead Sci U S A, 2006, 103(4):1006 -1011. DOI: lO.1073/pnas.0506982103.
6Li G, Thomas AM, Williams JA, et al. Farnesoid X receptor induces murine scavenger receptor Class B type I via intron binding[J]. PLoS One, 2012,7(4):e35895. DOI: 10.1371/ journal.pone.0035895.
7Li T, Matozel M, Boehme S, et al. Overexpression of cholesterol 7 ct-hydroxylase promotes hepatic bile acid synthesis and secretion and maintains cholesterol homeostasis[J].Hepatology, 2011,53(3):996-1006. DOI: 10.1002/hep.24107.
8Horton JD, Goldstein JL, Brown MS. SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver[J]. J Clin Invest, 2002, 109(9):1125-1131. DOI: 10.1172/ JCI15593.
9Watanabe M, Houten SM, Wang L, et al. Bile acids lower triglyceride levels via a pathway involving FXR, SHP, and SREBP- lc[J]. J Clin Invest, 2004, 113(10):1408-1418. DOI: 10.1172/JCI21025.
10Fuchs M. Non-alcoholic Fatty liver disease: the bile Acid- activated farncsoid x receptor as an emerging treatment target [J]. J Lipids, 2012, 2012:934396. DOI: 10.1155/2012/934396.
